Please login to the form below

Not currently logged in
Email:
Password:

Glenmark

This page shows the latest Glenmark news and features for those working in and with pharma, biotech and healthcare.

EMA suspends generic drugs on data integrity concerns

EMA suspends generic drugs on data integrity concerns

Included in the lengthy list of medicines affected by the suspension are products sold by Sandoz, Teva, Mylan, Sanofi, Biogaran Ratiopharm, Glenmark and Accord Healthcare, amongst many other firms, and most

Latest news

  • Indian court blocks generic of Merck's Januvia Indian court blocks generic of Merck's Januvia

    India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.

  • UCB files Vimpat patent claims against 15 companies UCB files Vimpat patent claims against 15 companies

    UCB files Vimpat patent claims against 15 companies. Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug. ... These other firms include major players in the generics market, such as Glenmark

  • Merck wins injunction against Januvia generics in India Merck wins injunction against Januvia generics in India

    The patent infringement case against Glenmark centred on the salt form of sitagliptin used in Zita and Zita Met. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on the market.

  • Merck & Co fails to block generic Januvia in India Merck & Co fails to block generic Januvia in India

    Merck &Co fails to block generic Januvia in India. Court says Glenmark can sell cheap copy of diabetes drug. ... of its price in the US – while Glenmark's versions are sold at a 20-30 per cent discount.

  • Bayer sues Glenmark over its skin disorder generic Bayer sues Glenmark over its skin disorder generic

    Bayer sues Glenmark over its skin disorder generic. India-based firm files for US approval of its version of Finacea. ... Bayer has launched a lawsuit against Glenmark Generics after the India-based firm filed for US approval of a generic version of skin

More from news
Approximately 4 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics